FinanceTimes of India
Pharma stocks bleed after Trump announces upto 200% tariff on generic drugs
in5points
US President Trump announced a phased tariff plan for imported generic medicines with duties up to 200% after a two-year tariff-free window.
Indian pharmaceutical stocks fell as companies reassess supply chains and investment plans due to potential future impacts.
Firms without US manufacturing presence may face significantly altered economics, encouraging domestic production in the US.
Story angle
Center-right
L
CL
C
CR
R
Mostly straight facts, with a light government- or market-friendly tilt.
About how the story is framed, not whether the facts are true.
Times of India
Center-right
Mixed factuality
Who owns this?
Times Group
Bennett, Coleman & Co. (Sahu Jain family)
India's largest newspaper group by circulation.
Wikipedia: Sahu Jain family